A host of global and domestic brokerages have released fresh views on Mankind Pharma, Divi's Laboratories, Asian Paints, ...
BD's board authorized the company to repurchase up to 10 million shares of its common stock in addition to those remaining under previous authorizations. The medical technology company said Tuesday it ...
AIM ImmunoTech Inc. (NYSE American: AIM) - AIM ImmunoTech Inc. ('AIM” or the 'Company”), an immuno-pharma company focused on ...
Zacks Investment Research on MSN
3 healthcare ETFs to buy as flat Medicare rate proposal hits insurers
The Trump administration has sent shockwaves through the healthcare sector by proposing nearly flat reimbursement rates for Medicare Advantage (MA) plans for 2027. Announced on Jan. 26, 2026, the ...
Novo Nordisk stock will ride a wave of demand for Ozempic pills in 2026.
Shares of Revolution Medicines RVMD slipped 17% yesterday after a Wall Street Journal (WSJ) report said, quoting people familiar with the matter, that pharma bigwig Merck MRK was no longer pursuing ...
India’s landmark FTA with the European Union, dubbed the “mother of all deals,” is reshaping investor focus as tariff cuts and regulatory easing promise a structural export boost. Textiles, ...
Fulgent Genetics' diagnostics business is growing, with 15.4% revenue growth YTD and all segments contributing. Read why I ...
Eli Lilly and Viking Therapeutics both operate in the high-growth field of obesity drugs. This market is forecast to reach ...
Investors are apparently taking bets on when Revolution will be acquired. A handful of pharmas could be interested as Merck ...
Dow Jones Top Company Headlines at 3 AM ET: Merck No Longer in Talks to Buy Revolution Medicines | Chinese ... The drugmaker had recently been in discussions to acquire RevMed in a deal that could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results